Persistent Coagulase-Negative Staphylococcal Bacteremia in Neonates: Clinical, Microbiological Characteristics and Changes within a Decade
Abstract
:1. Introduction
2. Results
3. Discussion
4. Materials and Methods
5. Conclusions
Author Contributions
Funding
Institutional Review Board Statement
Informed Consent Statement
Data Availability Statement
Conflicts of Interest
References
- De Buck, J.; Ha, V.; Naushad, S.; Nobrega, D.; Luby, C.; Middleton, J.; De Vliegher, S.; Barkema, H. Non-aureus Staphylococci and Bovine Udder Health: Current Understanding and Knowledge Gups. Vet. Infect. Dis. 2021, 8, 658031. [Google Scholar] [CrossRef] [PubMed]
- Widerström, M.; Wiström, J.; Sjöstedt, A.; Monsen, T. Coagulase-negative staphylococci: Update on the molecular epidemiology and clinical presentation, with a focus on Staphylococcus epidermidis and Staphylococcus saprophyticus. Eur. J. Clin. Microbiol. Infect. Dis. 2011, 31, 7–20. [Google Scholar] [CrossRef] [PubMed]
- Venkatesh, M.; Placencia, F.; Weisman, L. Coagulase-negative staphylococcal infections in the neonate and child: An update. Semin. Pediatr. Infect. Dis. 2006, 17, 120–127. [Google Scholar] [CrossRef] [PubMed]
- Wei, S.H.; Chiu, H.H.; Hung, K.C. Epidemiologic trends in nosocomial bacteremia in a neonatal intensive care unit. J. Microbiol. Immunol. Infect. 2005, 38, 283–288. [Google Scholar] [PubMed]
- Van den Hoogen, A.; Gerards, L.J.; Verboon-Maciolek, M.A. Long-term trends in the epidemiology of neonatal sepsis and antibiotic susceptibility of causative agents. Neonatology 2010, 97, 22–28. [Google Scholar] [CrossRef]
- Hornik, C.P.; Fort, P.; Clark, R.H. Early and late onset sepsis in very-low-birthweight infants from a large group of neonatal intensive care units. Early Hum. Dev. 2012, 88, S69–S74. [Google Scholar] [CrossRef] [Green Version]
- Vergnano, S.; Menson, E.; Kennea, N.; Embleton, N.; Russell, A.B.; Watts, T.; Robinson, M.J.; Collinson, A.; Heath, P.T. Neonatal infections in England: The NeonIN surveillance network. Arch. Dis. Child. Fetal Neonatal Ed. 2011, 96, F9–F14. [Google Scholar] [CrossRef] [Green Version]
- Gkentzi, D.; Kortsalioudaki, C.; Cailes, B.C.; Zaoutis, T.; Kopsidas, J.; Tsolia, M.; Spyridis, N.; Siahanidou, S.; Sarafidis, K.; Heath, P.T.; et al. Neonatal Infection Surveillance Network in Greece. Epidemiology of infections and antimicrobial use in Greek Neonatal Units. Arch. Dis. Child. Fetal Neonatal Ed. 2019, 104, F293–F297. [Google Scholar] [CrossRef]
- Auriti, C.; Maccallini, A.; Di Liso, G.; Di Ciommo, V.; Ronchetti, M.P.; Orzalesi, M. Risk factors for nosocomial infections in a neonatal intensive-care unit. J. Hosp. Infect. 2003, 53, 25–30. [Google Scholar] [CrossRef]
- Craft, A.; Finer, N. Nosocomial coagulase negative staphylococcal (CONS) catheter-related sepsis in preterm infants: Definition, diagnosis, prophylaxis, and prevention. J. Perinatol. 2001, 21, 186–192. [Google Scholar] [CrossRef]
- Okada, Y.; Klein, N.J.; Van Saene, H.K.; Webb, G.; Holzel, H.; Pierro, A. Bactericidal activity against coagulase-negative staphylococci is impaired in infants receiving long-term parenteral nutrition. Ann. Surg. 2000, 231, 276–281. [Google Scholar] [CrossRef] [PubMed]
- Saiman, L. Strategies for prevention of nosocomial sepsis in the neonatal intensive care unit. Curr. Oopin. Pediatr. 2006, 18, 101–106. [Google Scholar] [CrossRef] [PubMed]
- Healy, C.M.; Palazzi, D.L.; Edwards, M.S.; Campbell, J.R.; Baker, C.J. Features of invasive staphylococcal disease in neonates. Pediatrics 2004, 11, 953–961. [Google Scholar] [CrossRef] [PubMed]
- Cantey, J.B.; Anderson, K.R.; Kalagiri, R.R.; Mallett, L.H. Morbidity and mortality of coagulase-negative staphylococcal sepsis in very-low-birth-weight infants. World J. Pediatr. 2018, 14, 269–273. [Google Scholar] [CrossRef]
- Khashu, M.; Osiovich, H.; Henry, D.; Al Khotani, A.; Solimano, A.; Speert, D.P. Persistent bacteremia and severe thrombocytopenia caused by coagulase-negative Staphylococcus in a neonatal intensive care unit. Pediatrics 2006, 117, 340–348. [Google Scholar] [CrossRef]
- Anderson-Berry, A.; Brinton, B.; Lyden, E.; Faix, R.G. Risk factors associated with development of persistent coagulase-negative staphylococci bacteremia in the neonate and associated short-term and discharge morbidities. Neonatology 2010, 99, 23–31. [Google Scholar] [CrossRef]
- Dimitriou, G.; Fouzas, S.; Giormezis, N.; Giannakopoulos, I.; Tzifas, S.; Foka, A. Clinical and microbiological profile of persistent coagulase-negative staphylococcal bacteremia in neonates. Clin. Microbiol. Infect. 2011, 17, 1684–1690. [Google Scholar] [CrossRef] [Green Version]
- Linder, N.; Hernandez, A.; Amit, L.; Klinger, G.; Ashkenazi, S.; Levy, I. Persistent coagulase-negative staphylococci bacteremia in very-low-birth-weight infants. Eur. J. Pediatr. 2011, 170, 989–995. [Google Scholar] [CrossRef]
- Furuichi, M.; Miyairi, I. Risk factors for persistent bacteremia in infants with catheter-related bloodstream infection due to coagulase-negative Staphylococcus in the neonatal intensive care unit. J. Infect. Chemother. 2016, 22, 785–789. [Google Scholar] [CrossRef]
- O’Gara, J.P.; Humphreys, H. Staphylococcus epidermidis biofilms: Importance and implications. J. Med. Microbiol. 2001, 50, 582–587. [Google Scholar] [CrossRef] [Green Version]
- Foster, T.J. Immune evasion by staphylococci. Nat. Rev. Microbiol. 2005, 3, 948–958. [Google Scholar] [CrossRef] [PubMed]
- Vogel, L.; Sloos, J.; Spaargaren, J.; Suiker, I.; Dijkshoorn, L. Biofilm production by Staphylococcus epidermidis isolates associated with catheter related bacteremia. Diagn. Microbiol. Infect. Dis. 2000, 36, 139–141. [Google Scholar] [CrossRef]
- Rohde, H.; Frankenberger, S.; Zahringer, U.; Mack, D. Structure, function and contribution of polysaccharide intercellular adhesin (PIA) to Staphylococcus epidermidis biofilm formation and pathogenesis of biomaterial-associated infections. Eur. J. Cell Biol. 2009, 89, 103–111. [Google Scholar] [CrossRef] [PubMed]
- Heilmann, C.; Schweitzer, O.; Gerke, C.; Vanittanakom, N.; Mack, D.; Gotz, F. Molecular basis of intercellular adhesion in the biofilm-forming Staphylococcus epidermidis. Mol. Microbiol. 1996, 20, 1083–1091. [Google Scholar] [CrossRef]
- Stewart, P.S.; Costerton, J.W. Antibiotic resistance of bacteria in biofilms. Lancet 2001, 358, 135–138. [Google Scholar] [CrossRef]
- Manandhar, S.; Singh, A.; Varma, A.; Pandey, S.; Shrivastava, N. Phenotypic and genotypic characterization of biofilm producing clinical coagulase negative staphylococci from Nepal and their antibiotic susceptibility pattern. Ann. Clin. Microbiol. Antimicrob. 2021, 20, 41. [Google Scholar] [CrossRef]
- John-Ugwuanya, A.; Obaro, G.; Obaro, S. A Systematic Review of Coagulase-Negative Staphylococci in Neonatal Sepsis. Clin. Microbiol. 2019, 8, 326. [Google Scholar] [CrossRef]
- Ceballos, K.; Waterman, K.; Hulett, T.; Beth Flynn Makic, M. Nurse-Driven Quality Improvement Interventions to Reduce Hospital-Acquired Infection in the NICU. Adv. Neonatal Care 2013, 13, 154–163. [Google Scholar] [CrossRef]
- Harris, L.G.; Murray, S.; Pascoe, B.; Bray, J.; Meric, G.; Mageiros, L.; Wilkinson, T.S.; Jeeves, R.; Rohde, H.; Schwarz, S.; et al. Biofilm Morphotypes and Population Structure among Staphylococcus epidermidis from Commensal and Clinical Samples. PLoS ONE 2016, 11, e0154510. [Google Scholar] [CrossRef]
- Arciola, C.R.; Campoccia, D.; Ravaioli, S.; Montanaro, L. Polysaccharide intercellular adhesin in biofilm: Structural and regulatory aspects. Front. Cell. Infect. Microbiol. 2015, 5, 7. [Google Scholar] [CrossRef] [Green Version]
- Rabin, N.; Zheng, Y.; Opoku-Temeng, C.; Du, Y.; Bonsu, E.; Sintim, H.O. Biofilm formation mechanisms and targets for developing antibiofilm agents. Future Med. Chem. 2015, 7, 493–512. [Google Scholar] [CrossRef]
- Kontos, F.; Petinaki, E.; Spiliopoulou, I.; Maniati, M.; Maniatis, A. Evaluation of a novel method based on PCR restriction fragment length polymorphism analysis of the tuf gene for the identification of Staphylococcus species. J. Microbiol. Methods 2003, 55, 465–469. [Google Scholar] [CrossRef]
- Stepanović, S.; Vuković, D.; Hola, V.; Di Bonaventura, G.; Djukić, S.; Cirković, I.; Ruzicka, F. Quantification of biofilm in microtiter plates: Overview of testing conditions and practical recommendations for assessment of biofilm production by staphylococci. APMIS 2007, 115, 891–899. [Google Scholar] [CrossRef]
- Arciola, C.R.; Campoccia, D.; Gamberini, S.; Cervellati, M.; Donati, E.; Montanaro, L. Detection of slime production by means of an optimised Congo red agar plate test based on a colourimetric scale in Staphylococcus epidermidis clinical isolates genotyped for ica locus. Biomaterials 2002, 23, 4233–4239. [Google Scholar] [CrossRef]
- Petinaki, E.; Arvaniti, A.; Dimitracopoulos, G.; Spiliopoulou, I. Detection of mecA, mecR1 and mecI genes among clinical isolates of methicillinresistant staphylococci by combined polymerase chain reactions. J. Antimicrob. Chemother. 2001, 47, 297–304. [Google Scholar] [CrossRef] [Green Version]
Demographics | All Cases n = 56 | Persistent n = 14 | Non-Persistent n = 42 | p Value |
---|---|---|---|---|
Gender | ||||
Male | 28 | 5 | 23 | 0.217 a |
Female | 28 | 9 | 19 | |
Gestational age (weeks) * | 33.6 (3.7) | 34.4 (3.2) | 33.3 (3.9) | 0.403 b |
Birth weight (g) * | 2102 (973) | 2142 (823) | 2090 (1025) | 0.887 b |
Clinical practice risk factors | ||||
Intubation | 15 | 3 | 12 | 0.601 a |
Central indwelling catheters | 5 | 2 | 3 | 0.231 a |
Parenteral nutrition | 24 | 6 | 18 | 0.877 a |
Clinical characteristics | ||||
Temperature instability | 28 | 9 | 19 | 0.272 b |
Food intolerance | 31 | 8 | 23 | 0.877 a |
Respiratory deterioration | 16 | 4 | 12 | 0.601 a |
Circulatory deterioration | 7 | 4 | 3 | 0.036 a |
Laboratory indices | ||||
Thrombocytopenia (<80 × 109/L) | 7 | 3 | 4 | 0.243 a |
Severe thrombocytopenia (<30 × 109/L) | 2 | 1 | 1 | 0.406 a |
Maximum CRP (mg/dL) * | 7.1(5.4) | 12 (4.7) | 5.4 (4.8) | 0.000 b |
Days up to maximum CRP * | 1.96(0.9) | 2.71 (1.3) | 1.71 (0.7) | 0.001 b |
Demographics | 2006–2007 n = 72 | 2016–2017 n = 56 | p Value |
---|---|---|---|
Gender | |||
Male | 41 | 28 | 0.589 a |
Female | 31 | 28 | |
Gestational age (weeks) * | 32.6 (3.8) | 33.6 (3.7) | 0.164 b |
Birth weight (g) * | 2124 (735) | 2102 (973) | 0.888 b |
Clinical practice risk factors | |||
Intubation | 28 | 15 | 0.111 a |
Central indwelling catheters | 33 | 5 | 0.000 a |
Parenteral nutrition | 41 | 24 | 0.114 a |
Clinical characteristics | |||
Temperature instability | 52 | 28 | 0.038 a |
Food intolerance | 40 | 31 | 0.982 a |
Respiratory deterioration | 30 | 16 | 0.144 a |
Circulatory deterioration | 41 | 7 | 0.000 a |
Laboratory indices | |||
Thrombocytopenia (<80 × 109/L) | 37 | 7 | 0.000 a |
Severe thrombocytopenia (<30 × 109/L) | 25 | 2 | 0.000 a |
Maximum CRP (mg/dL) * | 8.1(6.091) | 7.1(5.4) | 0.330 b |
Days up to maximum CRP * | 2.16 (1.0) | 1.96 (0.9) | 0.279 b |
Demographics | Cases with Persistent CoNS Bacteremia | Cases with Non-Persistent CoNS Bacteremia | ||
---|---|---|---|---|
2006–2007 n = 29 | 2016–2017 n = 14 | 2006–2007 n = 43 | 2016–2017 n = 42 | |
Gender | ||||
Male | 16 | 5 | 25 | 23 |
Female | 13 | 9 | 18 | 19 |
Gestational age (weeks) * | 32 (3.8) | 34.4 (3.2) | 33 (3.7) | 33.3 (3.9) |
Birth weight (g) * | 1940 (736) | 2142 (823) | 2200 (725) | 2090 (1025) |
Clinical practice risk factors | ||||
Intubation | 16 | 3 ** | 12 | 12 |
Central indwelling catheters | 18 | 2 *** | 15 | 3 *** |
Parenteral nutrition | 17 | 6 | 24 | 18 |
Clinical characteristics | ||||
Temperature instability | 24 | 9 | 28 | 19 |
Food intolerance | 19 | 8 | 21 | 23 |
Respiratory deterioration | 14 | 4 | 16 | 12 |
Circulatory deterioration | 19 | 4 *** | 22 | 3 ** |
Laboratory indices | ||||
Thrombocytopenia (<80 × 109/L) | 27 | 3 ** | 10 | 4 |
Severe thrombocytopenia (<30 × 109/L) | 22 | 1 ** | 3 | 1 |
Maximum CRP (mg/dL) * | 8.9 (6.1) | 12 (4.7) | 4.0 (3.3) | 5.4 (4.8) |
Days up to maximum CRP * | 2 (0.7) | 2.71 (1.3) ** | 3 (1.0) | 1.71 (0.7) ** |
Persistent vs. Non-Persistent (2016–2017) | All Cases | Persistent | Non-Persistent | |||||
---|---|---|---|---|---|---|---|---|
Study Period | 2016–2017 | 2016–2017 | 2006–2007 | 2016–2017 | 2006–2007 | 2016–2017 | 2006–2007 | 2016–2017 |
Number of isolates | 98 | 69 | 170 | 167 | 97 | 98 | 73 | 69 |
ica-positive | 50 | 25 | 129 | 75 * | 74 | 50 * | 55 | 25 * |
Biofilm-positive | 50 | 26 | 107 | 76 * | 68 | 50 ** | 39 | 26 ** |
ica-positive/biofilm-positive | 50 | 22 | 91 | 72 | 59 | 50 | 32 | 22 |
ica-positive/biofilm-negative | 0 | 3 | 37 | 3 * | 14 | 0 * | 23 | 3 * |
ica-negative/biofilm-negative | 43 | 45 | 25 | 88 * | 14 | 43 * | 11 | 45 * |
ica-negative/biofilm-positive | 0 | 4 | 16 | 4 ** | 9 | 0 ** | 7 | 4 |
mecA-positive | 88 | 69 * | 166 | 157 | 93 | 88 | 73 | 69 |
β | Exp (β) | SE | Sig. | 95% for Exp (β) | ||
---|---|---|---|---|---|---|
Lower | Upper | |||||
Intubation | 0.211 | 1.235 | 1.143 | 0.854 | 0.132 | 11.591 |
Central indwelling catheters | 1.017 | 2.766 | 1.079 | 0.346 | 0.334 | 22.932 |
Severe thrombocytopenia (<30 × 109) | 3.587 | 36.139 | 1.264 | 0.005 | 3.037 | 43.083 |
Biofilm production | 2.464 | 11.747 | 1.210 | 0.042 | 1.095 | 125.979 |
Publisher’s Note: MDPI stays neutral with regard to jurisdictional claims in published maps and institutional affiliations. |
© 2022 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
Share and Cite
Bellou, V.; Gkentzi, D.; Giormezis, N.; Vervenioti, A.; Spiliopoulou, I.; Dimitriou, G. Persistent Coagulase-Negative Staphylococcal Bacteremia in Neonates: Clinical, Microbiological Characteristics and Changes within a Decade. Antibiotics 2022, 11, 765. https://doi.org/10.3390/antibiotics11060765
Bellou V, Gkentzi D, Giormezis N, Vervenioti A, Spiliopoulou I, Dimitriou G. Persistent Coagulase-Negative Staphylococcal Bacteremia in Neonates: Clinical, Microbiological Characteristics and Changes within a Decade. Antibiotics. 2022; 11(6):765. https://doi.org/10.3390/antibiotics11060765
Chicago/Turabian StyleBellou, Venetia, Despoina Gkentzi, Nikolaos Giormezis, Aggeliki Vervenioti, Iris Spiliopoulou, and Gabriel Dimitriou. 2022. "Persistent Coagulase-Negative Staphylococcal Bacteremia in Neonates: Clinical, Microbiological Characteristics and Changes within a Decade" Antibiotics 11, no. 6: 765. https://doi.org/10.3390/antibiotics11060765
APA StyleBellou, V., Gkentzi, D., Giormezis, N., Vervenioti, A., Spiliopoulou, I., & Dimitriou, G. (2022). Persistent Coagulase-Negative Staphylococcal Bacteremia in Neonates: Clinical, Microbiological Characteristics and Changes within a Decade. Antibiotics, 11(6), 765. https://doi.org/10.3390/antibiotics11060765